chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Congestion on day of 03/28/17. Was seen in office 03/28/2017 at 2:45 P.M., imm. given at 3:30 P.M. Mother took child to E.R. that night., due to stridor and admission with DECADRON injection given. Discharged 03/29/17 with Albuterol. 7:00 P.M. on, 3-28-17 child started with stridor cough. He went to E.R. and 1st vitals are documented at 22:41 on 03-28-17.
p/vax pt devel 4 lesions around inj site & 2 wk later devel 12 more lesions on different parts of the body;
pt incidently recieved  the Pfizer bivalent for their Primary Covid dose instead of the monovalent . no adverse reaction happened
Dizziness; Tinnitus; Confusion; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Dizziness), TINNITUS (Tinnitus) and CONFUSIONAL STATE (Confusion) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     The patient's past medical history included Cancer.    On 13-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced DIZZINESS (Dizziness), TINNITUS (Tinnitus) and CONFUSIONAL STATE (Confusion). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), TINNITUS (Tinnitus) and CONFUSIONAL STATE (Confusion) outcome was unknown.            Concomitant medication information was not provided.     This case was linked to MOD-2021-137462 (Patient Link).
Pain in the neck; Patient was not able to move her neck; This spontaneous case was reported by a patient and describes the occurrence of NECK PAIN (Pain in the neck) and MUSCULOSKELETAL STIFFNESS (Patient was not able to move her neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2022, the patient experienced NECK PAIN (Pain in the neck) and MUSCULOSKELETAL STIFFNESS (Patient was not able to move her neck). At the time of the report, NECK PAIN (Pain in the neck) and MUSCULOSKELETAL STIFFNESS (Patient was not able to move her neck) had not resolved.            No concomitant medication was reported. No treatment medications was reported.   Reporter did not allow further contact
8/27/09 pt came in this morning c/o hard, red swelling on arm at the site of injection from 2 days ago. Pt says it started yesterday morning, getting worse so they came (him and his mom). He said it is very itchy. Pt had received DTaP in 2006. So booster was preventative. Also, this was given Tdap, not DTaP.
headache resolved, sore throat resolved, productive cough, fever resolved, chills resolved, body aches resolved, left ear pain, sinus congestion, nasal congestion, post nasal drainage, sneezing. starting on 12/31/21
Pt recvd vax 7APR93 vax & died following day - was dx w/SIDS; autopsy performed;
pt recv vax 10NOV97 which was given ID by mistake;pt was to recv TB IDp4 to 5 wk post vax pt exp aches & pain @ inj site described as cellulitis;
I got the flu shot on 12/20/19 and on 12/26/19 I woke up with extreme weakness in my leggs and later pain in my feet and burning in my thighs with tingling in fingers and feet. I went to the Emergency Room on 1/2/20 for extreme weakness with suspicions of Guillain-Barre Syndrome, then discharged. A few days latter on 1/6/20 I returned later to the E.R. and was admitted to the hospital. In the hospital, tests included a spinal-tap that showed high protein and then was diagnosed with Guillain-Barre Syndrome. I spent seven days in the hospital and had 5 day treatments with intravenous immunglobg. I was released on 1/12/20 and started physical therapy to regain my walking ability. Physical therapy will be ongoing.
This case was reported by a nurse and described an adult male pt who did not respond to the hepatitis B vaccine recombinant (Engerix-B) immunization series.  The pt received injections of Engerix-B on 10/17/02 (LOT # ENG5374A4, 11/18/02 (LOT # ENG5371A4), 04/18/03( LOT # ENG5444A4).  On 05/19/03, a hepatitis B surface antibody titer was "negative".
Patient is of age to receive the vaccine. Per system it is only approved for dose 5 of DTAP and dose 4 OF IPV. Patient was behind on vaccines which made the DTAP 4th dose and IPV 3rd dose. Patient will receive to get the 4th dose of DTAP in 6 months.
Patient was working from home the day immediately prior to the day of vaccination. She was practicing as a Psych NP and remembered everything, patient names, dates of birth, medications, dosages, asked about adverse events , titrated medications, changed medications, pharmacy names and fax numbers etc. On Saturday she received the 1st Moderna shot, she came home and stayed home, no-one came into or out of our apartment then. She did not work on Monday, as previously agreed to. On Monday afternoon, she became flagrantly psychotic (no mental health history) and displayed and continues to display significant cognitive deficits, she is now wheelchair and bed bound, developed a blood clot in a vein in her brain, has had chronic UTIS, and her thyroid levels have been fluctuating quite a lot post vaccine. Her memory  continues to decline and her spike count is OVER 800. The working dx is Alzheimer's.
This spontaneous report as received from a medical assistant refers to a unspecified patients of unknown age and gender. The reporter stated that GARDASIL were exposed to 5 hours each day with a lowest temperature of 28 F from 03-JAN-2014 to 17-JAN-2014. The reporter also stated that during this time period, there were approximately 15 to 20 patients who received this vaccine. No adverse experiences reported. The outcome of the events were unknown. This is one of several reports from the same source.
First dose "knocked her out"; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (First dose "knocked her out") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced LOSS OF CONSCIOUSNESS (First dose "knocked her out") (seriousness criterion medically significant). At the time of the report, LOSS OF CONSCIOUSNESS (First dose "knocked her out") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Pt. states that after receiving the 1st dose of Phizer 07/06/2021 started experiencing feeling flushed and loose stool ending 07/24/2021. Experienced dehydration but maintained appetite. Scheduled for 2nd dose 07/27/2021
Day 1 thru Day 3 red, sore bruised injection site Narrative:
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in a 63 year old female subject, who was vaccinated with Engerix-B, hepatitis B vaccine for prophylaxis. The subject's medical history, concurrent conditions and concurrent medications were not reported. The subject received two three dose series of hepatitis B vaccine, one series in 1988 and one in 1993. The reporting nurse believed that the subject received Engerix-B (1.0 ml) for at least one of the series, but did not have specific information regarding brand, lot number or expiration dates. All doses of hepatitis B vaccine were given in the subject's left arm. The nurse stated that the subject did not sero-convert following either series of hepatitis B vaccine. The subject was not responding to therapy. No additional information was known at the time of reporting.
101.6 deg fever, very bad chills, and an extreme headache and body pain. Lasted from about 4:00pm to 11:00 the following day. Still feel weak and tired 48 hours later. Would have went the hospital under normal circumstances , but read these were the side effects for the vaccine.
During administration of vaccine the needle separated from the syringe. Vaccinator/nurse was unable to determine amount of vaccine that was administered to the patient.
Redness, warmth and mild pain at left upper arm - not deltoid treated with ROCEPHIN 1GM IM and P.O. Doxycycline 100mg BID x 7 days and P.O. BENADRYL. Wed May 11th Dr's office I got a pneumococcal shot. Thur 12th I felt fine. Fri 13 and Sat 14 I thought I had the flu I ached all over. Sun 15th my left arm was red and very hot from my elbow up my arm about 3 or 4 inches. Had fever in it. That lasted until May 20th. Mon 16th went back to Dr's office. The PA gave me a shot in my hip and called in for some pills. Wed 18th started taking the pills. Sun 22nd I began to feel better. Pills - Doxycycline Hyclate 100M.
This case was reported by a consumer via call center representative and described the occurrence of feeling abnormal in a male patient who received SHINGRIX for prophylaxis. On 16th July 2018, the patient received the 1st dose of SHINGRIX. On 16th July 2018, less than an hour after receiving SHINGRIX, the patient experienced feeling abnormal, headache, joint pain, injection site pain, decreased appetite and shoulder pain. On 19th July 2018, the outcome of the feeling abnormal, headache and decreased appetite were recovered/resolved and the outcome of the joint pain was unknown and the outcome of the injection site pain was not recovered/not resolved. On an unknown date, the outcome of the shoulder pain was not recovered/not resolved. It was unknown if the reporter considered the feeling abnormal, headache, joint pain, injection site pain, decreased appetite and shoulder pain to be related to SHINGRIX. Additional details were provided as follows: The reporter stated that he was not a healthcare professional but patient as this was the only way to mail GlaxoSmithKline. The reporter was the patient who was told by his doctor's office that GlaxoSmithKline would want to hear about and side effects from his recent SHINGRIX vaccination. The patient had received the SHINGRIX shot in his left shoulder muscle on and within an hour, he started to feel odd, a headache, joint pain, shot location pain and loss of desire to eat. These symptoms lasted through until Thursday evening. The patient did not feel any other symptoms such as fever, vomiting or diarrhea. The patient would receive the 2nd shot of SHINGRIX in early November 2018. The patient had agreed for follow up.
She had received her first shot on 7July2021 in another country, the second shot on the 7July2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (She had received her first shot on 7July2021 in another country, the second shot on the 7July2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (She had received her first shot on 7July2021 in another country,the second shot on the 7July2021). At the time of the report, INCORRECT DOSE ADMINISTERED (She had received her first shot on 7July2021 in another country,the second shot on the 7July2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided Concomitant medications were not reported
This is a spontaneous report from a contactable pharmacist. A 19-years-old female patient received TRUMENBA (Lot#W95309 Expiration date Jan2020), via an unspecified route of administration on 15Feb2019 at single dose for immunisation. Medical history included ongoing food allergy to pork, beef & turkey, ongoing diarrhea if the patient eats too many eggs. There were no concomitant medications.  The patient stated her arm was really hurting more and there was a little redness around the area of administration. The onset of the event was unknown. The reported events were considered non serious. The outcome of the two events were unknown.
Skin on whole body became red, hot and itchy.  Blister developed on stomach.  Took recommended doses of Benadryl for a 24 hour period.  The symptoms resolved. Blister is still visible nearly a month later.
After the shot pt was passing out. Very sweaty and cold. Eyes got rolled over. Called 911. They said the blood pressure has dropped and recommended to take her to hospital which pt denied.
Before the vaccine the patient was running 5-10 miles per day. After the vaccine the patient could no longer walk more than 5 minutes without developing severe fatigue. Later the patient was diagnosed with autonomic dysfunction and currently has to use a disability scooter. In patient?s health diary the first time ever the symptoms appear after the 1st Pfizer vaccine and become the worst after the 2nd Pfizer vaccine.
1 of 8 pts who recvd flu-imune exp pain @ inject site w/in 24 hrs of vax; pain lasted 1-5 days;
Maculopapular rashes on both extensor surfaces of thighs where received immunizations.
I take my blood pressure regularly.  In June I started to detect a meaningful difference in blood pressure in one arm verus the other - this was a new occurrence.  I went for an annual check-up on August 11th and pointed this out to my Doctor (who took my blood pressure in both arms and confirmed the condition that I had alerted them to).  She referred me to a cardiologist - who did an examination on September 23rd and also reported and confirmed the condition of a difference in BP between left and right arms.  He sent me for 3 tests including a Vascular Ultrasound which identified damage to the pulmonary artery
Patient received injection on 12/19/18 at 845 AM. At 11 PM patient presented to ER for tenderness and rash to left arm below the injection site.
This medically confirmed report (initial receipt: 14-May-2013) concerns a 60-year-old female patient. The patient had an allergy to MSG (monosodium glutamate). 3 years ago, exact date not specified, the patient received a flu shot (manufacturer and batch number not specified). 6 weeks after vaccination the patient developed Bell's palsy. The patient visited the emergency room but was not admitted to hospital. 3 years later the patient has not fully recovered, she continued to experience right side weakness. No further information was provided.
Semi-severe flu symptoms appearing about  three hours post-injection.  Treated with Tylenol and rest/sleep. Lasted about 12 hours, gradually lessening.
Starting October 2021, I went to urgent care due to a recurring cough. They sent me to the ER due to low oxygen. Then I had a CT scan and they said my lungs looked like a COVID patient but I ended up testing negative for it. At this point, I had been 2 months post partum (full term/normal birth and normal birth weight). I was sent home on oxygen for about a month (2 weeks full time and 2 weeks only at night time). Then, I saw my PCP and kept monitoring my oxygen. He thought it was a virus but unsure what. My oxygen was still not high enough to get off the oxygen so I had a repeat CT done in January and it showed similar "ground glass opacities" that are found in COVID patients. So, my PCP thought I had a virus similar to that of COVID but still was testing negative. Then, he sent me to a pulmonologist because if it was any other virus my lungs should've healed by now. I saw the pulmonologist who did 15 different blood tests to rule out autoimmune issues and I did another detailed CT scans and a couple of heart tests. After all that, blood work came back normal, heart tests were normal and the detailed CT showed slight improvement compared to January. So, the pulmonologist assumed I likely had caught COVID and that I was just testing negative. I'm still using oxygen while working out and a steroid inhaler on a daily basis. The pulmonologist thinks I should improve over the next month or two.
Pfizer vaccine given @ 0956. After vaccine administration, client drove her car to the recovery area and met with the nurse, to show her direction of where to wait for recovery. client informed her, "I think I'm having an allergic reaction." Nurse asked her to describe what symptoms she is having. Client stated that she had an itchy throat, she felt that she couldn't breathe, and her heart was racing. Nurse activated RRT. At 10:00, Nurse responded to scene with the Kit containing the AED, oxygen, and emergency medication. Vitals taken: P: 102, RR: 18, Manual BP: 120/80, Oxygen: 100% RA, no pain. Upon assessment, stethoscope used, clear lungs sounds, normal heart sounds. Client AAO x4, speaking in full sentences, no SOB noted. Skin color normal, capillary refill <3 seconds. Lip color normal. Nurse noted that client's lymph nodes were swollen. Throughout event, client spoke with no SOB and in clear sentences. EMS arrived to scene at 10:09 am. Vitals: HR: 99, 100% RA, 146/98. At this point, client is reporting feeling much better, head-to-toe assessment appears normal. She refused transport via ambulance to the hospital. EMS left scene at 10:20 am. Client was instructed to wait for 30 more minutes for monitoring. Client left scene at 10:30 am with client feeling better. Lymph nodes are no longer swollen, client continues to speak in full sentences with no SOB noted. Skin and lip color normal. Client AA0x4. Client instructed that if she is needing medical attention, feeling SOB, etc., to call 911 or go to the nearest hospital.
inadvertently administered an expired Bexsero; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 49-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA93AA, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st March 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 1st March 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The reporter was a practice manager. The reporter stated that they inadvertently administered an expired Bexsero dose to the patient, the vaccine was expired on 28th February 2022, which led to expired vaccine used. The reported called to inquired for any recommendation for such situation. The reporter did not consent to follow up.
Patient 17 yo female.  Patient's mother presents with her requesting meningitis vaccination for school. Neither mother nor patient have any documentation of which meningitis vaccination her school is requesting.  We continue with Trumenba and explain a follow up dose will be needed.  After researching School Immunization Requirements, a single dose of Menactra was more likely the shot she needed.  Trumenba is still recommended for this patient, but not required.  Patient will proceed to get a Menactra vaccination from us.  No adverse events have been reported at this point and may continue with series.  Patient simply received the wrong meningitis her school requires.
My daily tinnitus increased greatly; the frontal headaches; dizziness returned; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9266, Expiry Date: Not Reported), via an unspecified route, administered in Left Arm on 22Feb2021 at 08:45, as dose 2, single for covid-19 immunisation; and topiramate (TOPIRAMATE, batch/lot number: Unknown, Dose: Unknown), via an unspecified route of administration, on an unspecified start and stop date, for an unspecified indication. The patient was not pregnant at the time of vaccination. The patient medical history included complex regional pain syndrome (CPRS), neutropenia, leukopenia, sustained concussion from Feb2018 for two years, frontal headaches not ongoing, dizziness when bending over which was not ongoing; and ongoing tinnitus. The patient's concomitant medications in two weeks included only 2 tablets, a week prior as sleep aid. The patient did not receive other vaccine in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient had no known allergies. On 23Feb2021 at 6:00 AM, the patient's frontal headaches and dizziness returned, and daily tinnitus increased greatly. The patient reported two days after onset, the headache and dizziness have decreased in severity but not the tinnitus. The patient had all the same reactions with Topiramate. The patient anticipated that the patient would return to normal. The patient did not receive any treatment for the reported events. Outcome of the event tinnitus was not resolved and the outcome all other events was resolving.   No follow-up attempts are possible. No further information is expected
Information has been received from a physician concerning a 3 year old pre-school patient who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient developed a breakthrough rash that was diagnosed as varicella. It was reported that the patient passed it on to his 8 month old unimmunized sibling (WAES0504USA00706). Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
My chicks became swollen, Back of neck started swelling as well as my shoulders; It feels like my neck is asleep; This spontaneous case was reported by a patient and describes the occurrence of OEDEMA (My chicks became swollen, Back of neck started swelling as well as my shoulders) and HYPOAESTHESIA (It feels like my neck is asleep) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A, and 001B21A) for COVID-19 immunisation.     No medical history was provided by reporter.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced OEDEMA (My chicks became swollen, Back of neck started swelling as well as my shoulders) and HYPOAESTHESIA (It feels like my neck is asleep). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 200 mg as required. At the time of the report, OEDEMA (My chicks became swollen, Back of neck started swelling as well as my shoulders) and HYPOAESTHESIA (It feels like my neck is asleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  Action taken with respect to mRNA-1273 was not applicable.   This case was linked to MOD-2021-095552, MOD-2021-095552 (Patient Link).
pt recv vax & 36hr later child devel a rash on both arms;the rash lasted for approx 1wk;